Incannex Healthcare (IXHL) Total Current Liabilities (2020 - 2026)
Incannex Healthcare (IXHL) posted quarterly Total Current Liabilities of $1.9 million for Q1 2026, down 73.85% year-on-year from $7.4 million in Q1 2025, and up 24.56% on a QoQ basis from $1.5 million in Q4 2025.
Incannex Healthcare (IXHL) Total Current Liabilities (2020 - 2026) Analysis & Trends
Incannex Healthcare (IXHL) has reported Total Current Liabilities for 7 consecutive years, with $1.9 million the latest figure, recorded in Q1 2026.
- Quarterly Total Current Liabilities fell 73.85% year-over-year to $1.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.9 million (down 73.85% YoY) and the FY2025 annual result came in at $7.0 million, up 24.27% from the prior year.
- Total Current Liabilities rose to $1.9 million in Q1 2026 per IXHL's latest filing, from $1.5 million in the prior quarter.
- Over the last five years, Total Current Liabilities for IXHL reached as high as $9.2 million in Q3 2024 and fell as low as $1.1 million in Q4 2022.
- A 5-year average of $4.0 million and a median of $2.9 million in 2024 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2023 — Total Current Liabilities jumped 184.57% — and 2025, when it plunged 82.15%.
- Year by year, Total Current Liabilities stood at $1.1 million in 2022, then soared by 184.57% to $3.2 million in 2023, then surged by 83.3% to $5.8 million in 2024, then plunged by 73.51% to $1.5 million in 2025, then grew by 24.56% to $1.9 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $1.9 million, $1.5 million, and $1.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.56 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.53 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 18.06 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 599.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 6.81 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 831.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.66 Bn |
| 10 | Incannex Healthcare | 3.63 Mn | 3.63 Mn | - | 1.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.93 Mn |
| Dec 31, 2025 | 1.55 Mn |
| Sep 30, 2025 | 1.65 Mn |
| Jun 30, 2025 | 6.98 Mn |
| Mar 31, 2025 | 7.37 Mn |
| Dec 31, 2024 | 5.84 Mn |
| Sep 30, 2024 | 9.23 Mn |
| Jun 30, 2024 | 5.62 Mn |
| Mar 31, 2024 | 2.86 Mn |
| Dec 31, 2023 | 3.19 Mn |
| Jun 30, 2023 | 2.55 Mn |
| Dec 31, 2022 | 1.12 Mn |
| Jun 30, 2022 | 2.01 Mn |
| Jun 30, 2021 | 755,049.00 |
| Jun 30, 2020 | 1.07 Mn |